Manufacturing Influenza vaccines
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | SEQIRUS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $280,000 |
| Client | Filings | Total Income |
|---|---|---|
| SEQIRUS | 45 | — |
| Name | Disclosed Prior Position |
|---|---|
| CHRISTINE FARQUHARSON | OMB, Health Division, Program Examiner (2010-2021) |
| PHYLLIS FROSST |